Cell-cell adhesion is essential for many immunological functions and is believed to be important in the regulation of hematopoiesis. Adhesive interactions between human endothelial cells and megakaryocytes were characterized in vitro using the CMK megakaryocytic cell line as well as marrow megakaryocytes. Although there was no adhesion between unactivated human umbilical vein endothelial cells ( These observations suggest that alterations in megakaryocyte adhesion may occur during inflammatory conditions, mediated by certain cytokines, resulting in augmented megakaryocyte maturation. (J. Clin. Invest. 1993. 91:2378-2384
Introduction
Adhesion molecules play a major part in cell-matrix and in cell-cell interactions ( 1) . These adhesive interactions are important in the regulation ofhematopoiesis and thymocyte maturation, the direction and the control oflymphocyte traffic and migration through tissues, and the development of immune and nonimmune inflammatory responses (2) . Adhesion molecules belong to three different families: integrins (3), immunoglobulins (4), and selectins (5) . Integrins are expressed by a large number oftissues whereas other adhesion molecule families are restricted to a smaller number of cell types. The leukocyte integrin family (3) is composed ofa/3 heterodimeric membrane glycoproteins that share a common 1B subunit, designated CD 18. The a subunits of each of the three members, lymphocyte function associated antigen-1 (LFA-1) (2), macrophage antigen-1 (Mac-1 ) and p1 50,95 are designated CDl la, b, and c respectively. These adhesion molecules play a critical part in the immune and inflammatory responses of leukocytes. Another integrin subfamily found on leukocytes is the very late after activation antigens (VLA) group (6) . Members of this family function mainly as extracellular matrix adhesion receptors and are found both on hematopoietic and nonhematopoietic cells. A third integrin subfamily, the cytoadhesions, are receptors on platelets and endothelial cells, which bind extracellular matrix proteins (7, 8) . The immunoglobulin superfamily ofadhesion receptors, which include CD2 and ICAM-1, participate in T cell adhesive interactions and the antigen-specific receptors ofT and B cells, CD4, CD8, and the MHC class I and II molecules (9) . The third family of adhesion receptors is the selectins, characterized by a common lectin domain. Inducible endothelial leukocyte adhesion molecule-I (ELAM-1) ( 10, 11 ) and granule membrane protein (GMP-140) (5, 12) are expressed on stimulated endothelial cells and activated platelets.
The integrin family consists of at least 17 distinct heterodimers formed by associations between 13 a subunits and 7 different d subunits, each with distinct ligand-binding properties ( 13 ) . Among integrins, the VLA-5 complex is widely distributed and functions as a receptor for fibronectin ( 14, 15) . In contrast, the VLA-4 complex is expressed at substantial levels on normal peripheral blood B and T-cells, thymocytes, monocytes, and some melanoma cells, as well as on marrow blast cells and erythroblasts ( 16, 17) . Ligands for VLA-4 are vascular cell adhesion molecule-I (VCAM-1), identified on the surface of activated endothelial cells (18) (19) (20) (21) and CS-1, an alternately spliced domain within the Hep II region of fibronectin (22, 23) .
The regulation of megakaryocyte proliferation and differentiation appears to be controlled by a number ofsoluble mediators as well as cell-cell interactions (24) . The major stromal elements in the bone marrow microenvironment include cells of mesenchymal, endothelial, and macrophage origin. Systematic study ofthe effects of cytokines derived from each of these stromal elements, as well as adhesive interactions of these cell types with human megakaryocytes, may improve our understanding of regulation of megakaryocytopoiesis under physiological and disease conditions. In the bone marrow, megakaryocytes are located in the extravascular space applied to the abluminal surface of endothelium (25) (26) (27) . In this location, megakaryocytes send cytoplasmic projections into the lumen, which could serve to anchor the cell to the endothelium (25, 26) . The interaction ofrat and guinea pig megakaryocytes with subendothelial extracellular matrix was associated with adhesion, platelet-like shape changes and thromboxane A2 productions (28) . However, characterization of these adhesion interactions in the marrow microenvironment is not well defined.
To that end, we initially studied the interaction ofhuman megakaryocytes with bone marrow fibroblasts and observed that a number of adhesion molecules on the surface of megakaryocytes may mediate interaction with bone marrow fibroblasts, particularly the c-kit protooncogene product on the megakaryocyte surface with the membrane-bound form of the stem cell factor/kit ligand (SCF/KL) expressed on the marrow fibroblast (29) . We have now investigated the adhesive interactions between human megakaryocytes and endothelial cells. It appears that megakaryocyte-endothelial cell adhesive interactions differ in their nature compared with those with bone marrow stromal fibroblasts, suggesting that different stromal cell populations may have different roles in regulation of megakaryocytopoiesis.
Methods
Growth factors and reagents. Human SCF/KL was cloned and expressed in Escherichia coli and purified as previously described (30) . Recombinant human SCF/KL, human IL-3, human GM-CSF, and human IL-6 were provided by Amgen Biologicals (Thousand Oaks, CA). Recombinant human IL-1#, INF-,y, and tumor necrosis factor-a (TNF-a) were provided by Dr. C. Dinarello (Tufts University, Boston, MA). These cytokines were determined to be free ofendotoxin contamination. Plateau doses of each factor were determined from dose-response curves and used for culture at the following concentrations: 100 ng/ml SCF/KL; ng ml TNF-a 50; 1,000 ng/ml IFN--y; 10 ng/ml IL-6; 10 ng/ml IL-18l; 10 ng ml IL-3; and 200 ng/ml GM-CSF. Cycloheximide and actinomycin D were purchased from Sigma Chemical Co. (St. Louis, MO).
Megakaryocytic cells. Human bone marrow was obtained by aspiration from the iliac crest of normal donors who gave informed consent in a protocol approved by the New England Deaconess Hospital Institutional Review Board. The marrow was aspirated into preservativefree heparin (Sigma Chemical Co.) and separated by centrifugation through Ficoll-Hypaque (Pharmacia Inc., Piscataway, NJ) at 1 ,200gat room temperature for 30 min. Human marrow megakaryocytes were isolated by a method using immunomagnetic beads using anti-human glycoprotein GpIIb/IIIa monoclonal antibody as described previously (31 ) . All ofthe isolated cells were morphologically recognizable megakaryocytes. Growth factors were added to the cultures and were incubated for 16 h at 370C in a 5% CO2 humidified atmosphere.
The CMK cell line, provided by Dr. T. Sato, derived from a child with megakaryoblastic leukemia, has properties ofcells of megakaryocytic lineage, including surface expression ofglycoproteins lb and IIb/ Ila, synthesis of platelet factor 4, platelet-derived growth factor, von Willebrand's factor, and becomes polyploid upon induction with phorbol esters (32, 33) Sigma Chemical Co.) and 50 ,g/ml endothelial mitogen (Biomedical Technologies, Inc., Stoughton, MA). Tissue culture flasks were coated with 0.1% gelatin (Difco Laboratories, Inc., Detroit, MI) before passage of HUVEC. Second to fourth passage confluent cultures of HU-VEC were used. HUVEC were allowed to grow to confluence on gelatinized 24-well culture plates (-250,000 HUVEC per well). Confluence was verified by phase-contrast microscopy before use in experiments.
HUVEC activation. The ability of various stimuli to induce adhesion of HUVEC to megakaryocytes was investigated by preincubating HUVEC with various activating stimuli at 370C in a humidified atmosphere of 5% C02, 95% air for 24 h, unless otherwise indicated in the text. After this stimulation HUVEC were washed with warm (370C) medium and 100 ,l ofcell suspension (5 X 104 CMK or isolated megakaryocytes) were added to each well and HUVEC and megakaryocytes were allowed to incubate for up to 3 h as indicated in the text. All experiments were performed in duplicate. Cell-cell adhesion assay. To measure cell-cell adhesion, 5 x 104 CMK cells or bone marrow megakaryocytes in 2 ml of DMEM 10% + FCS were added to HUVEC. The cells were allowed to settle for 3 h at 37°C. Nonadherent cells were then washed away in four changes of medium, centrifuged at 400 g for 10 min, and counted. The remaining adherent cells were collected by vigorously pipeting trypan blue. To confirm the adherence of megakaryocytes to HUVEC, in some experiments we used radiolabeling with 5'Cr. Primary megakaryocytes or CMK cells (1O6) cells were labeled with 100 gCi of 5"Cr Na25PCrO4 for I h at 37°C and then washed twice in PBS and resuspended at 106 cells/ml. 5'Cr-labeled cells were added to each well with HUVEC in a total of 100 Ml and binding was allowed to occur for 3 h at 37°C. The nonadherent megakaryocytic cells were then removed by three washes with PBS, followed by lysis of bound cells with 0.1% NP-40. The radioactivity of each lysate was measured in a gamma counter, which was indicative of megakaryocyte cell adhesion.
For adhesion inhibition studies, we used the following monoclonal Effect oftemperature, cycloheximide, and actinomycin D on megakaryocyte adhesion to HUVEC. To examine the effect of temperature on CMK adhesion to HUVEC, HUVEC were first preincubated for 24 h at 370C with either IL-1 (10 ng/ml), PMA (10 ng/ml), TNF-a (50 ng/ml), or IFN--y (1,000 ng/ml). HUVEC were then washed with RPMI and CMK cells (5 x 104 cells) were then added to HUVEC for 3 h of adhesion at 4, 22, or 370C. CMK adhesion was measured as indicated above.
To examine the effect of the protein synthesis inhibitor cycloheximide and the RNA synthesis inhibitor actinomycin D, HUVEC were pretreated for 30 min with cycloheximide (1 jIg/ ml) or actinomycin D
( 1 gtg/ml) and then TNF-a(50 ng/ml) or PMA ( 10 ng/ml) was added for 24 h. HUVEC were then washed and CMK cells were added for 3 h. Adhesion of CMK cells was quantitated as described above.
Flow cytometric measurement of DNA content ofprimary megakaryocytes or CMK-G cells. CMK-G cells were plated in 24-well plates at 2 X 105/ml with 5% platelet-poor plasma for 5 d with or without IL-6 (10 ng/ml). In parallel, adhered CMK-G cells were cultured in 24-well plates containing unstimulated or TNF-a stimulated HUVEC at 2 X 105/ml, prelabeled with green fluorochrome, for 5 d as described (35) . CMK-G cells were then collected and washed twice with HBSS, resuspended in nuclei isolation medium (NIM-0.2% BSA, 0.4% provided p40 and 10 mM Hepes pH 7.4 in HBSS) plus 54 Worthington units/ml RNase A at 2 X 106/ml, and an equal volume of nuclei isolation medium containing 25 gg/ml propidium iodide (Sigma Chemical Co.) was then added. Samples were kept in the dark at 4°C and analyzed the same day on a FACSO scan using Cell Fit software as previously described (32) . Freshly prepared lymphocytes were used to mark the position of the 2N cells. The samples were analyzed for contamination with HUVEC cells by analyzing the CMK-G samples for green fluorochrome labeling.
Statistical analysis. The results were expressed as the mean±SEM of data obtained from three or more experiments performed in duplicate. Statistical significance was determined using the Student's t test. 
Results
Endothelial cell stimulation enhances adhesionfor megakaryocytes. In the absence of activating stimuli, adhesion of primary marrow megakaryocyte or CMK cells to HUVEC was < 5% (Fig. 1) . Treatment of HUVEC with IL-l,3, TNF-a, IFN-,y, or PMA resulted in dose-dependent increases in adherence of megakaryocytic cells to HUVEC. Optimal binding of primary marrow megakaryocytes and CMK to HUVEC was induced, respectively, by 10 ng/ml IL-lI3 (35.1±9%; 39±7%), 1,000 ng/ ml IFN-'y (37±10%; 42±8%), 50 ng/ml TNF-a (32±8%; 37±9%), and 10 ng/ml PMA (59±9%; 68±7%).
The adhesion kinetics of CMK megakaryocytic cells to HUVEC is shown in Fig. 2 formed with stimulated primary marrow megakaryocytes CMK cells and HUVEC. Fig. 4 illustrates that although unstii ulated megakaryocytes did not adhere to unstimulated Hi VEC, stimulation of megakaryocytes with the cytokines IL-I GM-CSF, IL-6, IL-3, or PMA induced adhesion ofmegakary cytes to unstimulated HUVEC with 2 20% adherence (Fig. 4 Activation of HUVEC with IFN--y or PMA resulted in furth enhancement of adhesion of cytokine-stimulated prima marrow megakaryocytes or CMK cells (Fig. 4) HUVEC were treated for 24 h as in Fig. 1 Figure 4 . Megakaryocyte adherence to HUVEC after stimulation of both cell types. HUVEC were stimulated for 24 h. CMK or bone marrow megakaryocytes (MK) were stimulated for 16 h as indicated in the figure. Cells were exposed to TNF-a (50 ng/ml), IFN--y ( 1,000 ng/ml), IL-1I( 10 ng/ml), GM-CSF(200 ng/ml), IL-6 ( 10 ng/ml), SCF ( 100 ng/ml), IL-3 (10 ng/ml), or PMA ( 10 ng/ml), as indicated in the figure. Values represent the mean±SEM of duplicate determinations in three experiments.
and ultimately form platelets (24, 35 (24, 32) (Table I) . Furthermore, DNA analysis of adhered CMK-G cells revealed a significant increase in the percentage of polyploid cells. The distribution of DNA content of the unstimulated CMK-G is shown in Table II . Stimulation by IL-6 of CMK-G cells increased the percentage ofpolyploid cells (Table  II) . Unstimulated CMK-G after adhesion to TNF-a-stimulated HUVEC demonstrated a higher distribution of DNA content compared with nonadhered CMK-G cells treated with the cytokine IL-6 (Table II) . Furthermore, IL-6-stimulated CMK-G cells adhered to TNF-a-stimulated HUVEC showed a further increase in the percentage of polyploid cells (Table   80 Human 
Discussion
Very little information has been obtained on cell-cell interaction between megakaryocytes and endothelial elements. Cultured HUVEC as well as cultured bovine endothelial cells produce an extensive underlying extracellular matrix that closely resembles the vascular subendothelial basal lamina in its origins and chemical composition (25) . Levine et al. (28) previously reported the use of cultured bovine endothelial cells as a model to study the interaction ofmegakaryocytes with the subendothelium. Bovine vascular endothelial cells were found to induce human platelet adhesion, aggregation, thromboxane A2 formation, and the release reaction in a manner similar to that observed with human platelets flowing over subendothelium from human arteries or veins (28) . HUVEC may also provide a model of bone marrow microvascular endothelial cells. Lichtman et al. (26) observed that an intimate relationship exists between the megakaryocyte and the abluminal surface of the endothelial lining cell. At the time of platelet release, the megakaryocyte cytoplasm invaginates and penetrates the endothelial lining cell; the penetrating cytoplasm is then detached and enters the marrow circulation as a packet of platelets that undergoes further fragmentation in the circulation. In addition, electron microscopic studies (25, 27) indicate that megakaryocytes in the extravascular compartments are preferentially located in the subendothelial region. In this location, they can send numerous organelle-free projections, which serve to anchor the cell to the endothelium, into the lumen. These observations indicate that megakaryocyte adhesion to endothelial cells in vivo is an important physiological process for platelet formation (25) . Therefore, characterization of adhesive interactions between megakaryocytes and endothelium should provide insights into thrombopoiesis under normal and disease states. Our studies suggest that inflammatory cytokines such as IL-1#, TNF-a, or IFN-,y, which are known to activate endothelium, can promote such adhesion. These cytokines that induce adhesion of HUVEC for megakaryocytes also induce adhesion of HUVEC for basophils (36) and for other granulocyte subpopulations, including neutrophils and eosinophils (37) (38) (39) . The kinetics of megakaryocyte adhesion and the induction of adhesion in HUVEC for megakaryocytes resemble that for granulocytes, and appears to require both RNA and protein synthesis, suggesting that megakaryocytes may be binding to the same inducible surface structures previously described for neutrophil, eosinophils, and basophil adherence (36) (37) (38) (39) . Furthermore, cytokines known to promote megakaryocyte growth and/or differentiation such as IL-3, GM-CSF, and IL-6 appear to augment the attachment of the megakaryocyte to endothelium.
We have demonstrated that incubation of megakaryocytes with antibodies directed against the common 1B subunit or against the a subunit of the CD1 8 complex lead to marked inhibition ofadhesion ofmegakaryocytes to HUVEC. The finding that blockade ofthe ,B and a subunits with specific antibodies does not completely inhibit megakaryocyte adherence to stimulated HUVEC indicates that additional cell-surface structures are important for endothelial cell-megakaryocytic interactions. In this regard, we observed that megakaryocytes expressed VLA-4, which interacted with VCAM-I expressed on the surface of HUVEC. This is in addition to the 32 integrins that interact with ICAM-1 expressed on activated HUVEC.
The VLA-4/VCAM-1 adhesion pathway has been implicated in important physiological processes involving migration and localization of immune cells ( 18, 19, 40, 41 ) and some tumor cells ( 17) . In the present study, we observed that this pathway can also play a role in mediating adhesion of megakaryocytes to endothelial cells. Our studies also identified the specific ,32 integrins, the LFA-1 complex, as involved in megakaryocyte adhesion. Although participation of VLA-4 and 62 integrins accounted for most of the adhesion, other adhesive molecules may also contribute to this process. Further experiments using multiple antibody combinations may help resolve this question.
Our characterization of megakaryocyte adhesion to two major marrow stromal elements, fibroblasts and endothelial cells, suggests that there may be alternative pathways ofcytoadhesion involved in megakaryocytopoiesis. In a previous study, we observed that megakaryocytes adhered to marrow stromal fibroblasts constitutively, using in part the membrane form of SCF/ KL on the fibroblast and its cognate c-kit receptor on the megakaryocyte. Increased megakaryocyte replication occurred with such adhesion to mesenchymal cells (29) . Maturational, rather than proliferative changes were observed upon megakaryocyte adhesion to endothelial cells. There may be a branch point in the pathway ofmegakaryocyte replication versus maturation that depends on interaction with stromal fibroblasts versus endothelium.
During inflammatory conditions, thrombocytosis due to increased megakaryocytopoiesis is often observed (24 
